Method of treating a disease using a glycolytic dependent compound
OwnerJames Galloway, Tamara BYK-TENNENBAUM +5inventors
InventorsJames Galloway, Tamara BYK-TENNENBAUM, Erez ILAN, Lior WEISSMAN, Sivan DORON, Eve MONTIA, Niels-Derrek Schmitz
Life of this patent
Estimating the term…
Abstract
Provided are implants and a glycolytic dependent compound for use in enhancing toxicity of the glycolytic dependent compound towards a cell, tissue and/or organ e.g., a diseased cell, tissue and/or organ, wherein the implant and the glycolytic dependent compound are contacted with the cell, tissue and/or organ in a non-blended form.
Claims20
A method of treating a diseased tissue in a subject in need using a glycolytic dependent compound, the method comprising the steps of:
- a) targeting the glycolytic dependent compound to the diseased tissue, by placing an implant in proximity to, adjacent to, or in direct connection with the tissue, and
- b) administering the glycolytic dependent compound to the subject,
- wherein the implant and the glycolytic dependent compound are administered in a non-blended form.
A method of enhancing toxicity of a glycolytic dependent compound towards a diseased cell, tissue and/or organ, the method comprising contacting an implant, and a glycolytic dependent compound with the cell, tissue and/or organ;
- wherein the implant and the glycolytic dependent compound are contacted with the cell, tissue and/or organ in a non-blended form.
Dependencies are inferred from the claim text.